Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan-Dec:11:23247096231171251.
doi: 10.1177/23247096231171251.

Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report

Affiliations
Case Reports

Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report

Asif Ali Hitawala et al. J Investig Med High Impact Case Rep. 2023 Jan-Dec.

Abstract

Systemic sclerosis (SSc) is an autoimmune disease characterized by progressive skin fibrosis. It has 2 main clinical subtypes-diffuse cutaneous scleroderma and limited cutaneous scleroderma. Non-cirrhotic portal hypertension (NCPH) is defined as presence of elevated portal vein pressures without cirrhosis. It is often a manifestation of an underlying systemic disease. On histopathology, NCPH may be found to be secondary to multiple abnormalities such as nodular regenerative hyperplasia (NRH) and obliterative portal venopathy. There have been reports of NCPH in patients with both subtypes of SSc secondary to NRH. However, simultaneous presence of obliterative portal venopathy has not been reported. We present a case of NCPH due to NRH and obliterative portal venopathy as a presenting sign of limited cutaneous scleroderma. The patient was initially found to have pancytopenia and splenomegaly and was erroneously labeled as cirrhosis. She underwent workup to rule out leukemia, which was negative. She was referred to our clinic and diagnosed with NCPH. Due to pancytopenia, she could not be started on immunosuppressive therapy for her SSc. Our case describes the presence of these unique pathological findings in the liver and highlights the importance of an aggressive search for an underlying condition in all patients diagnosed with NCPH.

Keywords: Raynaud phenomenon; elastography; idiopathic non-cirrhotic portal hypertension; systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Physical examination findings: (A) telangiectasias on mucosal aspect of lower lip; (B) sclerotic hyperpigmented plaque on the abdomen; (C) edematous swelling of hands; and (D) multiple sclerotic plaques on the bilateral lower extremities.
Figure 2.
Figure 2.
Changes of obliterative portal venopathy and nodular regenerative hyperplasia. (A) Portal area with small portal veins displaced out of the portal area (H&E, 400×). (B) Sinusoidal dilation (H&E, 200×). (C) Delicate perisinusoidal fibrosis (Masson trichrome, 400×). (D) Vague nodularity with zone of narrowed liver cell plates (arrows; Reticulin, 200×). Abbreviation: H&E, hematoxylin and eosin.

Similar articles

Cited by

References

    1. Sarin SK, Kumar A.Noncirrhotic portal hypertension. Clin Liver Dis. 2006;10:627-651. doi:10.1016/j.cld.2006.08.021 - DOI - PubMed
    1. Semela D.Systemic disease associated with noncirrhotic portal hypertension. Clin Liver Dis (Hoboken). 2015;6(4):103-106. doi:10.1002/cld.505 - DOI - PMC - PubMed
    1. Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM.Systemic sclerosis in adults. Part I: clinical features and pathogenesis. J Am Acad Dermatol. 2022;87(5):937-954. doi:10.1016/j.jaad.2021.10.065 - DOI - PubMed
    1. Denton CP, Khanna D.Systemic sclerosis. Lancet. 2017;390: 1685-1699. doi:10.1016/S0140-6736(17)30933-9 - DOI - PubMed
    1. Graf L, Dobrota R, Jordan S, Wildi LM, Distler O, Maurer B.Nodular regenerative hyperplasia of the liver: a rare vascular complication in systemic sclerosis. J Rheumatol. 2018;45(1): 103-106. doi:10.3899/jrheum.170292 - DOI - PubMed

Publication types